FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...
Amy Wu Silverman, RBC Capital Markets head of derivatives strategy, joins "Squawk Box' to discuss the latest market trends, ...
RBC Capital keeps an Outperform rating and $235 price target on Alphabet (GOOGL) after its Q4 results. The quarter keeps the AI Search bear ...
18h
Fintel on MSNRBC Capital Downgrades Olin (OLN)Fintel reports that on February 4, 2025, RBC Capital downgraded their outlook for Olin (NYSE:OLN) from Outperform to Sector ...
RBC Capital analyst Brad Erickson reiterated a Hold rating on Snap (SNAP – Research Report) today and set a price target of $16.00. The ...
Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...
The net proceeds to SmartCentres from the sale of the Series AB debentures, will be used to refinance existing debt, including the repayment of its $160 million Series N senior unsecured debentures ...
Base Metal Prices Mixed as Trade Tensions Continue to Unnerve Market -- Market Talk 0950 GMT - Base metal prices are mixed, with LME three-month copper flat at $9,174 a metric ton and LME three-month ...
Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the ...
RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...
Neumora Therapeutics Inc (NMRA) stock saw a modest uptick, ending the day at $1.91 which represents a slight increase of $0.05 or 2.69% from the prior close of $1.86. The stock opened at $1.87 and ...
Canadian stocks rose Tuesday after an agreement between Prime Minister Justin Trudeau’s government and the White House to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results